Neurocrine Biosciences Stock (NASDAQ: NBIX) stock price, news, charts, stock research, profile.
Open | $137.470 |
Close | $135.990 |
Volume / Avg. | 717.575K / 878.564K |
Day Range | 135.170 - 138.630 |
52 Wk Range | 89.040 - 148.370 |
Market Cap | $13.678B |
P/E Ratio | 55.773 |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 49 |
Short Interest | 2.82% |
Days to Cover | 2.44 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Neurocrine Biosciences (NASDAQ: NBIX) through any online brokerage.
Other companies in Neurocrine Biosciences’s space includes: Legend Biotech (NASDAQ:LEGN), Sarepta Therapeutics (NASDAQ:SRPT), Exact Sciences (NASDAQ:EXAS), Cerevel Therapeutics Hldg (NASDAQ:CERE) and Roivant Sciences (NASDAQ:ROIV).
The latest price target for Neurocrine Biosciences (NASDAQ: NBIX) was reported by Wells Fargo on Wednesday, April 24, 2024. The analyst firm set a price target for 170.00 expecting NBIX to rise to within 12 months (a possible 25.01% upside). 61 analyst firms have reported ratings in the last year.
The stock price for Neurocrine Biosciences (NASDAQ: NBIX) is $135.99 last updated April 26, 2024 at 4:00 PM EDT.
There are no upcoming dividends for Neurocrine Biosciences.
Neurocrine Biosciences’s Q1 earnings are confirmed for Wednesday, May 1, 2024.
There is no upcoming split for Neurocrine Biosciences.
Neurocrine Biosciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.